Drug Shortage Report for INVOKAMET
Report ID | 199839 |
Drug Identification Number | 02455455 |
Brand name | INVOKAMET |
Common or Proper name | INVOKAMET 150/1000MG |
Company Name | JANSSEN INC |
Market Status | MARKETED |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE CANAGLIFLOZIN |
Strength(s) | 1000MG 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | A10BD |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2023-12-18 |
Actual start date | |
Estimated end date | 2024-01-06 |
Actual end date | 2023-10-13 |
Shortage status | Avoided shortage |
Updated date | 2023-10-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 19 GREEN BELT DRIVE TORONTO, ONTARIO CANADA M3C 1L9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-10-13 | French | Compare |
v5 | 2023-10-13 | English | Compare |
v4 | 2023-09-13 | French | Compare |
v3 | 2023-09-13 | English | Compare |
v2 | 2023-07-24 | French | Compare |
v1 | 2023-07-24 | English | Compare |
Showing 1 to 6 of 6